Completes; pretest 3

Market Claims in Direct-to-Consumer Prescription Drug Print Ads

Market Claims in DTC Rx Print Ads Appendix A

Completes; pretest 3

OMB: 0910-0824

Document [pdf]
Download: pdf | pdf
Appendix A:
Informed Consent and Recruitment Emails

Market Claims in DTC Advertisements
Informed Consent
[Consent Screen 1]
Ipsos, a national market research and public opinion firm, is conducting a research study on behalf of a
public health agency to gain a better understanding of how consumers perceive advertisements (ads) that
appear in magazines and newspapers.
The study will involve viewing a prescription drug ad and answering questions related to the ad. Your
answers are private and confidential. No one will ever be able to connect your name with these answers.
Your input is extremely valuable. There is no direct benefit to you for participating. However, you may find
the interview to be informative or interesting. Your responses are very important because they will help
researchers understand how people make decisions about medications. There are no known risks to
participating in this study. While the survey questions we ask are not meant to be sensitive, there is
always a chance that you may feel uncomfortable with some of the questions. You do not have to answer
any question that you don’t want to answer. There is also a potential risk of loss of confidentiality. Every
effort will be made to protect your information, but this cannot be guaranteed.
If you have questions about this survey, please contact Dr. Aysha Keisler, the project director. She can be
reached between 9 AM and 5 PM Eastern Standard Time Monday – Friday at (202)-420-2021.
This study will take about 30 minutes to complete and you will earn 180 iSay points in appreciation of
your time. We ask that you complete the survey in one sitting (without taking any breaks) to avoid
distractions.
Rights as a Participant
If you have any questions about your rights as a participant, you may wish to contact Ipsos’s Office of
Research Protection at (202) 420-2013.
Privacy and Confidentiality
As with other surveys you receive from Ipsos, the privacy and confidentiality of your information is of the
highest importance, and we are committed to maintaining a secure environment in which you can
participate. All information collected in this survey will be kept confidential to the extent provided by law.
Your name and your e-mail address will not be shared outside of Ipsos, and they will not be associated
with your answers or used in any report.
[SHOW AT BOTTOM OF SCREEN IN SLIGHTLY SMALL FONT]
DHHS research authorized by Section 1701(a)(4) of the Public Health Service Act (42 U.S.C. 300u(a)(4)).
Confidentiality protected by 5 U.S.C. 552(a) and (b) and 21 CFR part 20.
OMB Control #: ___________
Expires _______________

[Consent Screen 2]
[SINGLE SELECT]
[PROMPT IF SKIP]
Consent1. If you have read the previous screen and agree to participate, please click the Yes
button. If not, click the No button.
_ Yes, I agree to participate. [SKIP Consent2]
_ No, I do not agree to participate. [CONTINUE TO Consent2]
[SINGLE SELECT]
[PROMPT IF SKIP]
[IF CONSENT1 = NO OR SKIP]
Consent2. Are you sure you don't want to participate? Your opinions are important to us. Please
select the Yes button to continue this survey. Select the No button to exit.
_ Yes, I agree to participate. [CONTINUE].
_ No, I do not agree to participate. [TERMINATE].

Market Claims in DTC Advertisements
Informed Consent

[Consent Screen 1]
Ipsos, a national market research and public opinion firm, is conducting a research study on
behalf of a public health agency to gain a better understanding of how consumers perceive
advertisements (ads) that appear in magazines and newspapers.
The study will involve viewing a prescription drug ad and answering questions related to the ad.
Your answers are private and confidential. No one will ever be able to connect your name with
these answers. Your input is extremely valuable. There is no direct benefit to you for
participating. However, you may find the interview to be informative or interesting. Your
responses are very important because they will help researchers understand how people make
decisions about medications. There are no known risks to participating in this study. While the
survey questions we ask are not meant to be sensitive, there is always a chance that you may feel
uncomfortable with some of the questions. You do not have to answer any question that you
don’t want to answer. There is also a potential risk of loss of confidentiality. Every effort will be
made to protect your information, but this cannot be guaranteed.
If you have questions about this survey, please contact Dr. Aysha Keisler, the project director.
She can be reached between 9 AM and 5 PM Eastern Standard Time Monday – Friday at (202)420-2021.
This study will take about 15 minutes to complete and you will earn 90 iSay points in
appreciation of your time. We ask that you complete the survey in one sitting (without taking
any breaks) to avoid distractions.
Rights as a Participant
If you have any questions about your rights as a participant, you may wish to contact Ipsos’s
Office of Research Protection at (202) 420-2013.
Privacy and Confidentiality
As with other surveys you receive from Ipsos, the privacy and confidentiality of your
information is of the highest importance, and we are committed to maintaining a secure
environment in which you can participate. All information collected in this survey will be kept
confidential to the extent provided by law. Your name and your e-mail address will not be shared
outside of Ipsos, and they will not be associated with your answers or used in any report.
[SHOW AT BOTTOM OF SCREEN IN SLIGHTLY SMALL FONT]
DHHS research authorized by Section 1701(a)(4) of the Public Health Service Act (42 U.S.C. 300u(a)(4)).
Confidentiality protected by 5 U.S.C. 552(a) and (b) and 21 CFR part 20.
OMB Control #: ___________
Expires _______________

[Consent Screen 2]
[SINGLE SELECT]
[PROMPT IF SKIP]
Consent1. If you have read the previous screen and agree to participate, please click the
Yes button. If not, click the No button.
_Yes, I agree to participate. [SKIP Consent2]
_No, I do not agree to participate. [CONTINUE TO Consent2]
[SINGLE SELECT]
[PROMPT IF SKIP]
[IF CONSENT1 = NO OR SKIP]
Consent2. Are you sure you don't want to participate? Your opinions are important to us.
Please select the Yes button to continue this survey. Select the No button to exit.
_Yes, I agree to participate. [CONTINUE].
_No, I do not agree to participate. [TERMINATE].

 
 
 
 
 
 
 
 
 
 
 
 

Recruitment and Reminder Emails


File Typeapplication/pdf
File TitleMicrosoft Word - Appendix A consent and recruitment.doc
AuthorDHC
File Modified2016-07-25
File Created2016-07-25

© 2024 OMB.report | Privacy Policy